| Literature DB >> 28035958 |
Lu Zhao1, Jin-Cheol Kim2, Man-Jeong Paik3, Wonjae Lee4, Jae-Seoun Hur5.
Abstract
Lichens are considered a great bio-resource because they produce large numbers of secondary metabolites with many biological activities; however, they have not been cultivated under artificial conditions to date. As a result, lichen substances from natural sources are limited and have not been widely utilized in commercial applications. Accordingly, interest in lichen-associated fungi, especially endogenic fungi, has increased. Ultraviolet (UV) radiation in sunlight is harmful to human health, resulting in demand for effective UV filtering agents for use in sunscreen. In this study, we purified (3R)-5-hydroxymellein, which has UVA absorption activity, from the secondary metabolites of an endolichenic fungus (ELF000039). The antioxidant properties were then assessed by in vitro tests. The antioxidant activity of (3R)-5-hydroxymellein was high when compared to the recognized antioxidants ascorbic acid (ASA) and butyl hydroxyl anisole (BHA). Moreover, the compound exhibited no cytotoxicity toward mouse melanoma cell lines, B16F1 and B16F10, or the normal cell line, HaCaT. Furthermore, (3R)-5-hydroxymellein recovered the damage caused by UVB irradiation and inhibited melanin synthesis. Taken together, these results suggest that (3R)-5-hydroxymellein could have an interesting and vital profile to go further development as a multifunctional skin UV protectant.Entities:
Keywords: (3R)-5-hydroxymellein; UV protection; antioxidant; endolichenic fungus; melanin
Mesh:
Substances:
Year: 2016 PMID: 28035958 PMCID: PMC6155896 DOI: 10.3390/molecules22010026
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1UV spectrum of ELF000039 crude extract after 28 days of culture. The orange line is the UV spectral baseline of the solvent (ethanol).
Figure 2(A) TLC analysis of the main fractions of ELF000039 crude extract under UV light; (B–D) UV spectra of three main fractions (F1, F2, and F3). The blue line is the UV spectral baseline of the solvent.
Figure 3(A) HPLC chromatogram of the purified single compound acquired at 254 nm. The molecular structure of (3R)-5-hydroxymellein is presented in the insets; (B) UV spectra of the purified single compound (0.2 mg/mL).
Antioxidant activities (IC50; μg/mL) of ELF000039 crude extract, purified F2 ((3R)-5-hydroxymellein), and positive controls (ASA and BHA).
| Compound | DPPH Scavenging Activity | Reducing Power | Superoxide Anion Scavenging Activity | Inhibition of Linoleic Acid Peroxidation |
|---|---|---|---|---|
| Crude extract | 1812.8 ± 270.3 | ND a | >2000 | >2000 |
| (3 | 30.8 ± 1.4 | 1170.8 ± 22.1 | 645.3 ± 5.7 | 501.8 ± 5.3 |
| ASA | 40.8 ± 2.9 | 1127.9 ± 12.0 | - | 755.8 ± 27.3 |
| BHA | - b | - | >1000 | - |
a no data; b not tested; data are the means ± SD (n = 3).
Figure 4Bioautographic TLC assay of ELF000039 crude extract. (A) Crude extract developed on a TLC plate under UV light; (B) TLC plate sprayed with DPPH methanol solution under visible light; (C) TLC plate sprayed with 10% H2SO4 under visible light.
Antimicrobial activities (inhibition zone diameters, mm) of ELF000039 crude extract, purified F2 ((3R)-5-hydroxymellein), and reference antibiotics against microorganisms.
| Compound | Microorganism | |||||
|---|---|---|---|---|---|---|
| Crude extract (1 mg) | 0 | PI 12.2 ± 0.8 | 0 | 0 | 10.6 ± 0.9 | 0 |
| (3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vancomycin (0.1 mg) | - | - a | 12.5 ± 0.9 | 16.9 ± 1.4 | 16.4 ± 0.9 | - |
| Cefotaxime (0.1 mg) | 0 | 28.3 ± 1.1 | - | - | - | - |
| Ketoconazole (0.1 mg) | - | - | - | - | - | 39.8 ± 0.4 |
a not tested; data are the means ± SD (n = 3).
Viabilities of three cell lines treated with different concentrations of (3R)-5-hydroxymellein.
| Cell Line | Concentration (µg/mL) | ||||
|---|---|---|---|---|---|
| 100 | 50 | 25 | 12.5 | 6.25 | |
| B16F1 | 92.2 ± 10.6 | 105.3 ± 1.3 | 109.8 ± 4.9 | 100.5 ± 0.7 | 99.9 ± 5.3 |
| B16F10 | 99.6 ± 10.1 | 114.6 ± 4.3 | 109.9 ± 9.5 | 110.0 ± 6.2 | 103.0 ± 3.6 |
| HaCaT | 96.5 ± 5.8 | 94.5 ± 4.3 | 101.1 ± 5.1 | 116.8 ± 13.1 | 89.3 ± 8.1 |
Data are the means ± SD (n = 3).
Figure 5HaCaT cell viability after treatment with ELF000039 purified F2 ((3R)-5-hydroxymellein) and UVB irradiation. The cell survival without UVB was considered 100%; DMSO was a negative control. Data shown are the means ± SD (n = 3).
Figure 6Effects of ELF000039 purified F2 ((3R)-5-hydroxymellein) on melanin synthesis in B16F1 cells. Cells were treated with different concentrations of (3R)-5-hydroxymellein or ASA under 20 nM of α-MSH. (A) Melanin content percentage was expressed and the melanin content of cells without α-MSH was considered 100%. DMSO was used as a negative control; (B) Melanin synthesis inhibition of (3R)-5-hydroxymellein and ASA under 20 nM of α-MSH compared to DMSO. Data shown are the means ± SD, n = 3.